THAP1 and Dystonia: First, the identification of THAP1 as a critical activator of PSMB5 expression suggests that proteasome dysfunction could underlie the pathogenesis of DYT-THAP1, although, to the best of our knowledge, no other mutations in proteasome genes have so far been associated with dystonia.